tirzepatide visceral fat isn't a weight drug. It's an inflammation drug that happens to help with weight. That's why it's quietly changing the MCAS conversation. Dual GLP-1 / GIP agonist. GLP-1 slows gut motility The RISKS & BENEFITS of

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

GLP-1 agonists were originally approved by the U.S

Cold compresses and antihistamines may help reduce these symptoms

One large placebo-controlled trial (presented at the AUA meeting in 2007) tested intranasal bremelanotide in 726 men with ED (average age 55) over 12 weeks

OR, Overweight: having a body mass index of 27 kg/m2 or higher) AND, Having at least one weight-related complication such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnea

Even though we now know it is a complex, chronic disease with hormonal and genetic drivers, many insurance companies still exclude treatment, especially medications, from their coverage. Does Medicare cover weight loss medication